MiniMed 780G advanced hybrid closed-loop system use during days without user-initiated boluses
Niu F, Liu M, Yovanovich C, et al.
Diabetes Care. Pub. online 7 Jan 2026.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Associations of moderate-to-vigorous physical activity timing with type 2 diabetes incidence in UK Biobank and prevalent glycemic measures in NHANES
Feng Q, Albalak G, Ao L, et al.
Diabetes Care. Pub. online 9 Jan 2026.
Leggi
Association between GLP-1 receptor agonists and ischemic optic neuropathy: a meta-analysis
Nogueira A, Rassi TNO, Iqbal A, et al.
Diabetes Care. Pub. online 7 Jan 2026.
Leggi
Effects of lifestyle interventions in pregnancy on gestational diabetes: individual participant data and network meta-analysis
Allotey J, Coomar D, Ensor J, et al.
BMJ. Pub. online 6 Jan 2026.
Leggi
Long-term effects of a multidomain intervention on cognitive function and metabolic control in older adults with type 2 diabetes and mild cognitive impairment: a 42-month follow-up of the J-MIND-Diabetes study
Sugimoto T, Omura T, Araki A, et al.
Diabetes Obes Metab. Pub. online 8 Jan 2026.
Leggi
The results of ProHCL: patient-reported outcomes in people living with type 1 diabetes on hybrid closed-loop insulin pump therapy – experiences from the NHS England pilot
Griffin TP, Hagan J, Chauhan R, et al.
Diabetes Res Clin Pract. Pub. online 6 Jan 2026.
Leggi
Can the Diabetes Eating Problem Survey-Revised (DEPS-R) reliably identify eating disorder diagnosis in women with type 1 diabetes?
Haugvik S, Hennekes MHCL, de Wit M, et al.
Diabet Med. Pub. online 8 Jan 2026.
Leggi
Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes
Kishimori T, Kato T, Iwasaki Y, et al.
Diabetes Obes Metab. Pub. online 5 Jan 2026.
Leggi
Sex differences in trial representation and the cardiovascular effectiveness of newer glucose-lowering agents in patients with and without type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Zawadka M, Taguiam E, Lê ML, et al.
Diabetes Obes Metab. Pub. online 8 Jan 2026.
Leggi
Effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists on diabetic foot disease : an emulated target trial
Kristensen FPB, Christensen DH, Callaghan BC, et al.
Ann Intern Med. Pub. online 6 Jan 2026.
Leggi